Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.83 is 15% above its 4-year average of -6.86, around the middle of its 4-year range (-16.50–1.83).
8.62% above its 12-month average of -6.38.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.52.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 8 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:43:25.168Z. Historical observations retain their original dates. Historical series through 2023-03-31.
EARNINGS PER SHARE (EPS)
-5.83
EARNINGS PER SHARE (EPS) AVG TTM
-6.38
EARNINGS PER SHARE (EPS) AVG 3Y
-3.64
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.62%
CURRENT VS 3Y AVG
-60.09%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tevogen Bio Holdings Inc.
Market Cap
$27.03M
Earnings Per Share (EPS)
-5.83
TTM Avg
-6.38
3Y Avg
-3.64
5Y Avg
N/A
Market Cap
$27.79M
Earnings Per Share (EPS)
-0.62
TTM Avg
-0.83
3Y Avg
-1.05
5Y Avg
-1.29
Market Cap
$28.08M
Earnings Per Share (EPS)
-2.41
TTM Avg
-9.11
3Y Avg
-20.57
5Y Avg
-19.82
Market Cap
$28.10M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.19
3Y Avg
-0.10
5Y Avg
-0.07
Market Cap
$28.31M
Earnings Per Share (EPS)
-1.63
TTM Avg
-2.10
3Y Avg
-19.25
5Y Avg
-13.48
Market Cap
$28.47M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
Market Cap
$25.22M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.41
3Y Avg
-1.95
5Y Avg
-2.99
Market Cap
$29.37M
Earnings Per Share (EPS)
-1.87
TTM Avg
-12.30
3Y Avg
-40.98
5Y Avg
-45.74
Market Cap
$24.60M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.76
3Y Avg
-1.17
5Y Avg
-2.27
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. (TVGN) | $27.03M | -5.83 | -6.38 | -3.64 | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | -0.62 | -0.83 | -1.05 | -1.29 |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | -2.41 | -9.11 | -20.57 | -19.82 |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | N/A | -0.19 | -0.10 | -0.07 |
| OneMedNet Corporation (ONMD)vs › | $28.31M | -1.63 | -2.10 | -19.25 | -13.48 |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | -0.17 | -0.24 | -0.47 | -0.92 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | -0.29 | -0.41 | -1.95 | -2.99 |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -1.87 | -12.30 | -40.98 | -45.74 |
| InspireMD, Inc. (NSPR)vs › | $24.60M | -0.50 | -0.76 | -1.17 | -2.27 |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | -0.48 | -0.42 | -0.82 | -1.14 |
Trailing EPS (TTM)
$-5.83
Forward EPS (Est.)
$-10.14
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -8.08 |
| 2024-12-31 | -4.68 |
| 2022-12-31 | 1.83 |
| 2021-12-31 | -16.50 |
